Comparative study of Epidural 0.75% Ropivacaine with Dexmedetomidine and 0.75% Ropivacaine alone in lower abdominal and lower limb surgeries
Keywords:
Dexmedetomidine, Ropivacaine, Epidural BlockAbstract
Background
Epidural anaesthesia is one of the most common regional anaesthetic
techniques used for lower abdominal and lower limb surgeries. The advantages
of epidural anaesthesia being, it provides effective surgical anaesthesia and can
meet the extended duration of surgical needs, provides prolonged post
operative analgesia, reduces the incidence of hemodynamic changes. Various
adjuvants are being used with local anesthetics for prolongation of intra
operative and postoperative analgesia in epidural block for lower abdominal
and limb surgeries. Dexmedetomidine, the highly selective ?2 adrenergic
agonist is a new neuroaxial adjuvant gaining popularity.
Aim
To study the synergistic effect of adding dexmedetomidine to ropivacaine
0.75% in epidural anaesthesia for lower abdominal and lower limb
surgeries.
Materials and Methods
One Hundred Patients scheduled for various lower abdominal and lower limb surgeries under epidural
anesthesia participated in this study. They were assigned to: Control Group (n = 50), 15ml of 0.75% ropivacaine
and Dexmedetomidine Group (n = 50), 15ml of 0.75% ropivacaine plus 0.6mcg. Kg-1 of dexmedetomidine. The
Following variables were studied: onset of sensory and motor block, duration of sensory and motor block,
maximal dermatomal level of analgesia.
Results
Dexmedetomidine group had rapid onset of action (p<0.05), prolonged duration of sensory and motor block
(p<0.05), postoperative analgesia (p<0.05), and determine more intense motor block (p<0.05).There was no
difference in the maximal dermatomal level of analgesia.
CONCLUSION
Epidural Dexmedetomidine as an adjuvant to Ropivacaine is associated with prolonged sensory and motor
block, hemodynamic stability, prolonged postoperative analgesia and reduced demand for rescue analgesics
when compared to plain Ropivacaine.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.